Shockwave Medical, Inc. Common Stock
SWAV
SWAV was delisted on the 30th of May, 2024.
92 hedge funds and large institutions have $495M invested in Shockwave Medical, Inc. Common Stock in 2019 Q3 according to their latest regulatory filings, with 23 funds opening new positions, 36 increasing their positions, 14 reducing their positions, and 21 closing their positions.
157% more repeat investments, than reductions
Existing positions increased: 36 | Existing positions reduced: 14
2% more funds holding
Funds holding: 90 → 92 (+2)
10% more first-time investments, than exits
New positions opened: 23 | Existing positions closed: 21
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
35% less capital invested
Capital invested by funds: $758M → $495M (-$263M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$66M |
| 2 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$18.1M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
+$15.4M |
| 4 |
LM
Luminus Management
Houston,
Texas
|
+$13.8M |
| 5 |
GGHC
Gilder Gagnon Howe & Co
New York
|
+$9.75M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RCM
RA Capital Management
Boston,
Massachusetts
|
-$28.3M |
| 2 |
DM
Deerfield Management
New York
|
-$17.8M |
| 3 |
SAM
Sectoral Asset Management
Montreal,
Quebec, Canada
|
-$11.7M |
| 4 |
VMI
VHCP Management II
New York
|
-$10.8M |
| 5 |
PA
Perceptive Advisors
New York
|
-$8.56M |
SWAV Hedge Fund Activity: Q3 2019 in Review
92 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in Shockwave Medical, Inc. Common Stock (SWAV) for Q3 2019, worth a combined $495M — down 35% from $758M a quarter earlier.
Buyers outnumbered sellers: 23 funds opened new SWAV positions and 21 closed out — a net gain of 2 holders — while 36 added to existing stakes and 14 trimmed.
The largest buyer was T. Rowe Price Associates, adding an estimated $66M. The largest seller was RA Capital Management, exiting entirely with an estimated $28.3M sold.
- 92 institutional investors held Shockwave Medical, Inc. Common Stock (SWAV) as of Q3 2019, up from 90 in Q2 2019.
- Funds reported $495M of Shockwave Medical, Inc. Common Stock stock for Q3 2019, down 35% quarter-over-quarter.
- 23 funds opened new Shockwave Medical, Inc. Common Stock positions in Q3 2019 and 21 closed out, a net change of +2 holders.
- The largest Shockwave Medical, Inc. Common Stock buyer in Q3 2019 was T. Rowe Price Associates, an estimated $66M added.
- The largest Shockwave Medical, Inc. Common Stock seller in Q3 2019 was RA Capital Management, an estimated $28.3M sold.
Based on aggregated 13F filings for Q3 2019.